Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

He Yao

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|March 6, 2013
[Progress of anti-tumor study based on BRAF]Gui-Rui Yan, Zhi-Jian Xu, He-Yao Wang, et al.
Molecular and Cellular Biochemistry|May 5, 2009
Inhibition of hepatic stellate cell proliferation by heat shock protein 90 inhibitors in vitroXu Sun, Xiao-Dong Zhang, Gang Cheng, et al.
Chinese Medical Journal|August 14, 2012
White blood cells contribute to patient-specific warfarin dose for Han ChineseJin Zhu, Wen-Jie Zheng, Wei-Juan Zhang, et al.
Chemistry & Biodiversity|December 19, 2009
New isoprenylated 2-arylbenzofurans and pancreatic lipase inhibitory constituents from Artocarpus nitidusTing Zhao, Gui-Rui Yan, Sheng-Li Pan, et al.
Journal of Medicinal Chemistry|March 10, 2017
Discovery of Potent and Orally Bioavailable GPR40 Full Agonists Bearing Thiophen-2-ylpropanoic Acid ScaffoldHe Li, Qi Huang, Cheng Chen, et al.
Chemistry & Biodiversity|March 23, 2016
New Alkaloids and α-Glucosidase Inhibitory Flavonoids from Ficus hispidaZheng-Feng Shi, Chun Lei, Bang-Wei Yu, et al.
Journal of Diabetes|October 19, 2023
Impact of chiglitazar on glycemic control in type 2 diabetic patients with metabolic syndrome and insulin resistance: A pooled data analysis from two phase III trialsZhiqiang Ning, Guoqiang Ai, Bo Chen, et al.
Experimental Animals|October 18, 2003
Establishment and characterization of the Komeda diabetes-prone rat as a segregating inbred strainNorihide Yokoi, Misako Namae, Masanori Fuse, et al.
Basic & Clinical Pharmacology & Toxicology|June 15, 2021
Combined treatment with FABP4 inhibitor ameliorates rosiglitazone-induced liver steatosis in obese diabetic db/db miceMeng-Ting Chen, Jun-Shang Huang, Ding-Ding Gao, et al.
Life Sciences|January 15, 2021
A novel GPR120-selective agonist promotes insulin secretion and improves chronic inflammationLiu Yang, Xian-Tao Lei, Qi Huang, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|March 6, 2013
[Progress of anti-tumor study based on BRAF]Gui-Rui Yan, Zhi-Jian Xu, He-Yao Wang, et al.
Molecular and Cellular Biochemistry|May 5, 2009
Inhibition of hepatic stellate cell proliferation by heat shock protein 90 inhibitors in vitroXu Sun, Xiao-Dong Zhang, Gang Cheng, et al.
Chinese Medical Journal|August 14, 2012
White blood cells contribute to patient-specific warfarin dose for Han ChineseJin Zhu, Wen-Jie Zheng, Wei-Juan Zhang, et al.
Chemistry & Biodiversity|December 19, 2009
New isoprenylated 2-arylbenzofurans and pancreatic lipase inhibitory constituents from Artocarpus nitidusTing Zhao, Gui-Rui Yan, Sheng-Li Pan, et al.
Journal of Medicinal Chemistry|March 10, 2017
Discovery of Potent and Orally Bioavailable GPR40 Full Agonists Bearing Thiophen-2-ylpropanoic Acid ScaffoldHe Li, Qi Huang, Cheng Chen, et al.
Chemistry & Biodiversity|March 23, 2016
New Alkaloids and α-Glucosidase Inhibitory Flavonoids from Ficus hispidaZheng-Feng Shi, Chun Lei, Bang-Wei Yu, et al.
Journal of Diabetes|October 19, 2023
Impact of chiglitazar on glycemic control in type 2 diabetic patients with metabolic syndrome and insulin resistance: A pooled data analysis from two phase III trialsZhiqiang Ning, Guoqiang Ai, Bo Chen, et al.
Experimental Animals|October 18, 2003
Establishment and characterization of the Komeda diabetes-prone rat as a segregating inbred strainNorihide Yokoi, Misako Namae, Masanori Fuse, et al.
Basic & Clinical Pharmacology & Toxicology|June 15, 2021
Combined treatment with FABP4 inhibitor ameliorates rosiglitazone-induced liver steatosis in obese diabetic db/db miceMeng-Ting Chen, Jun-Shang Huang, Ding-Ding Gao, et al.
Life Sciences|January 15, 2021
A novel GPR120-selective agonist promotes insulin secretion and improves chronic inflammationLiu Yang, Xian-Tao Lei, Qi Huang, et al.
Pageof 11